BIOVIE INC. Quarterly Common Stock, Shares, Issued from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Biovie Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2013 to Q3 2024.
  • Biovie Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 7.98M shares, a 78.4% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 7.98M -28.9M -78.4% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 6.22M +2.57M +70.5% Jun 30, 2024 10-Q 2024-11-13
Q1 2024 61M +24.9M +68.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 39.9M +5.36M +15.5% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 36.9M +6.76M +22.4% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 3.65M -21.3M -85.4% Jun 30, 2023 10-K 2024-09-30
Q1 2023 36.2M +11.2M +44.7% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 34.5M +9.52M +38.1% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 30.2M +5.2M +20.8% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 25M +2.65M +11.9% Jun 30, 2022 10-K 2023-08-16
Q1 2022 25M +11M +79% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 25M +11.1M +79.5% Dec 31, 2021 10-Q 2022-02-08
Q3 2021 25M +11M +79.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 22.3M +17.1M +329% Jun 30, 2021 10-K 2022-09-27
Q1 2021 14M +8.76M +168% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 13.9M +8.73M +168% Dec 31, 2020 10-Q 2021-01-29
Q3 2020 13.9M -634M -97.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 5.2M +1.15M +28.2% Jun 30, 2020 10-K 2021-08-30
Q1 2020 5.2M -311M -98.4% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 5.18M -310M -98.4% Dec 31, 2019 10-Q 2020-02-13
Q3 2019 648M +333M +106% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 4.06M -94.4M -95.9% Jun 30, 2019 10-K/A 2020-08-07
Q1 2019 316M +219M +225% May 10, 2019 10-Q 2019-05-10
Q4 2018 315M +220M +232% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 315M +220M +233% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 98.5M +6.58M +7.16% Jun 30, 2018 10-K 2019-09-27
Q1 2018 97.3M +5.65M +6.16% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 95M +7.29M +8.31% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 94.6M +7.38M +8.47% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 91.9M +4.77M +5.47% Jun 30, 2017 10-K 2018-10-05
Q1 2017 91.7M +4.48M +5.13% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 87.7M +475K +0.55% Dec 31, 2016 10-Q 2017-02-07
Q3 2016 87.2M 0 0% Sep 30, 2016 10-Q/A 2017-01-19
Q2 2016 87.2M -50K -0.06% Jun 30, 2016 10-K 2017-08-24
Q1 2016 87.2M 0 0% Mar 31, 2016 10-Q 2016-05-23
Q4 2015 87.2M 0 0% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 87.2M 0 0% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 87.2M 0 0% Jun 30, 2015 10-K 2016-09-28
Q1 2015 87.2M 0 0% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 87.2M Dec 31, 2014 10-Q 2015-02-05
Q3 2014 87.2M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 87.2M +150K +0.17% Jun 30, 2014 10-K 2015-10-01
Q1 2014 87.2M Mar 31, 2014 10-Q 2014-05-09
Q2 2013 87.1M Jun 30, 2013 10-K 2014-09-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.